This is a StreetInsider.com Premium Only Page

(BSEM) – Press Releases

Apr 2, 2024 08:00 AM BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference

Apr 1, 2024 04:05 PM BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase

Mar 21, 2024 08:00 AM BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024

Feb 26, 2024 10:39 AM PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market

Jan 30, 2024 04:05 PM Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies

Jan 11, 2024 08:30 AM BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role

Dec 19, 2023 08:30 AM BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors

Dec 14, 2023 08:30 AM Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions

Dec 13, 2023 08:30 AM BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors

Nov 13, 2023 05:17 PM BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results

Nov 8, 2023 08:30 AM BioStem Technologies Awarded Q Code for VENDAJE AC® Line from Centers for Medicare and Medicaid Services

Nov 3, 2023 08:30 AM BioStem Technologies Closes Oversubscribed $2M Private Placement

Sep 26, 2023 08:30 AM BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje(R) in Diabetic Foot Ulcers

Sep 14, 2023 08:00 AM NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft

Sep 11, 2023 08:00 AM NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft

Mar 23, 2023 07:30 AM BioStem Technologies Commends OIG's Recommendation for CMS to Address ASP Reporting Requirements for Skin Substitute Products

Mar 7, 2023 07:30 AM BioStem Technologies to Acquire Majority of Assets of Auxocell Laboratories, Inc.

Feb 14, 2023 08:55 AM BioStem Technologies Enters Into a Share Exchange Agreement

Feb 1, 2023 07:30 AM BioStem Technologies Poised for Growth with Two New Hires: Michael Sylvester Joins as Vice President of Sales, Neal Bhattacharya as Vice President of Marketing

Jan 24, 2023 07:30 AM Center for Medicare Services Established National Pricing of VENDAJETM in All MAC regions

Dec 16, 2022 07:30 AM BioStem Technologies Announces Up-Listing to the OTCQB Venture Market

Dec 14, 2022 07:30 AM BioStem Technologies Announces Partnership with Kill Cliff FC

Nov 15, 2022 04:05 PM BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results

Nov 15, 2022 07:30 AM BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call

Oct 26, 2022 07:30 AM BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer

Oct 10, 2022 07:30 AM BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference

Sep 13, 2022 07:30 AM BioStem Announces Publication of a Standardized Method to Evaluate Growth Factor Elution from Placental Tissue Allografts

Sep 8, 2022 07:30 AM BioStem Technologies Strengthens its Board of Directors and Audit Committee with the Appointment of Accomplished Medtech Financial Leader Brandon Poe

Aug 22, 2022 04:01 PM BioStem Technologies Reports Second Quarter 2022 Operating and Financial Results

Aug 16, 2022 07:30 AM BioStem Technologies to Host Second Quarter Financial Results and Corporate Update Conference Call on August 22nd

Jun 17, 2022 09:25 AM BioStem Technologies® CEO to Appear on the Benzinga All Access Show on June 17,2022

May 16, 2022 12:25 PM BioStem Technologies Reports March 31, 2022 Record Quarterly Financial Results

Apr 1, 2022 10:00 AM BioStem Technologies Inc. Reports December 31, 2021 Year End Financial Results

Nov 1, 2021 09:00 AM BioStem Technologies Announces Veterans Day Fundraiser to Support America's VetDogs®

Aug 25, 2021 11:15 AM BioStem Technologies Reports Record Breaking Second Quarter Sales

Jul 27, 2021 09:00 AM BioStem Technologies, Inc., Announces the Engagement of Biologics Consulting To Support FDA Strategies and Submissions.

Jul 23, 2021 09:00 AM BioStem Technologies, Inc. Awarded Q Code for VENDAJE® Product Line From CMS.

May 24, 2021 11:34 AM BioStem Technologies Announces Filing of 2021 First Quarter Financial Reports

Apr 20, 2021 09:00 AM BioStem Technologies, Inc., Announces the Addition of Three Key Scientific Advisory Board Members

Apr 15, 2021 09:00 AM BioStem Technologies, Inc. Announces Launch of National Sales Force Expansion

Apr 5, 2021 09:00 AM BioStem Technologies, Inc. Reports Financial Results for Fourth Quarter and Fiscal Year 2020

Mar 25, 2021 09:00 AM BioStem Technologies, Inc. Receives TRIP (TRG Rapid Inquiry Program) Response for VENDAJE™

Mar 15, 2021 09:00 AM BioStem Technologies Engages D. Brooks & Associates for 2020 and 2019 Audit

Dec 24, 2020 02:00 PM BioStem Technologies, Announces Filing of 2020 Quarterly Reports

Oct 27, 2020 09:00 AM BioStem Technologies, Inc. Announces Launch of AEON™

Sep 1, 2020 05:00 PM BioStem Technologies, in Partnership with Veterans Medical Distributors Inc., Announces Five-Year Federal Supply Schedule Contract with the Department of Veterans Affairs

Aug 11, 2020 09:00 AM BioStem Life Sciences Signs Manufacturing Agreement for Amniotic Membrane Allograft Platform

Jul 22, 2020 05:00 PM BioStem Technologies, Inc. Announces Update Regarding Timeline to Become Current Reporting with OTC Markets During Q4 2020

Jul 15, 2020 09:00 AM BioStem Life Sciences Receives Accreditation by The American Association of Tissue Banks® (AATB®)

Jul 2, 2020 09:00 AM BioStem Technologies, Inc. Announces Submission of Applications for Q-Codes from the Centers for Medicare and Medicaid Services (CMS)